Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00901771 · ClinicalTrials.gov registry record · NA
Study of Provent Treatment of Obstructive Sleep Apnea in Patients Who Are Non-compliant With CPAP
A NA study, sponsored by St. Luke's Hospital, Chesterfield, Missouri.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT00901771: Completed NA study, sponsored by St. Luke's Hospital, Chesterfield, Missouri.
NCT00901771 is a NA study that has completed, run by St. Luke's Hospital, Chesterfield, Missouri. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00901771, a NA study, has completed, sponsored by St. Luke's Hospital, Chesterfield, Missouri.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The primary objective of the proposed investigation is to evaluate the efficacy of the Provent device in a sample of OSA patients who have either refused or been non-adherent with PAP treatment. Both initial efficacy (evaluated after approximately one week with Provent) and efficacy after approximately 5 weeks in patients who demonstrate initial efficacy will be assessed. A secondary objective is to assess adherence with Provent treatment during the 5-week evaluation period.
Interventions
- DEVICE Provent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2009-05 |
| Est. Completion | 2009-12 |
| Phase | NA |
What the finished NCT00901771 record still lists
NCT00901771 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Provent is the first listed.
NCT00901771 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00901771 about?
NCT00901771 is a clinical study titled "Study of Provent Treatment of Obstructive Sleep Apnea in Patients Who Are Non-compliant With CPAP". The primary objective of the proposed investigation is to evaluate the efficacy of the Provent device in a sample of OSA patients who have either refused or been non-adherent with PAP treatment. Both initial efficacy (evaluated after approximately one week with Provent) and efficacy after approximat...
What is the current status of trial NCT00901771?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2009-05. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00901771?
The interventions under investigation include: Provent (DEVICE).
Who is sponsoring clinical trial NCT00901771?
This trial is sponsored by St. Luke's Hospital, Chesterfield, Missouri, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00901771's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia